Assort Health raises $120M Series C at $1.2B valuation for healthcare AI

What happened

On June 24, Assort Health announced a $120M Series C at a $1.2B valuation. Total funding now exceeds $222M.

Context and impact

AI agents for healthcare administrative workflows are one of the fastest-growing segments. Together with the day's other announcements (Coval, Runlayer, Taktile), it shows capital flooding into enterprise verticals with clear ROI.

Details

• Round led by Menlo Ventures with Lightspeed, Felicis, First Round, Chemistry, Joe Montana, Tau Ventures and Quiet Capital.
• Platform spans scheduling, intake, referrals, documents, medication refills, eligibility, lab requests and payments.
• Proprietary Synapse model trained on 190M+ patient interactions and 62,000 care protocols.
• Revenue grew 20x in the last 15 months.
• Customers report a 5% lift in appointment volume, 115% increase in labor capacity and 4.3/5 patient satisfaction.